This is part one of a two-part collaboration hosted by Nasdaq, AstraZeneca BioVentureHub and Sahlgrenska Science Park. Part two will take place at Sahlgrenska Science Park later in the spring 2017.
Who should attend?
This event is intended for anyone interested in biotech and life science company funding.
An open session featuring presentations and a panel discussion will provide useful insights on the best ways for small life science companies to raise capital to generate big value.
After a networking opportunity and buffet dinner, Nasdaq will host a more intimate surgery session for companies who want to learn more about the practicalities of a stock listing.
Main topics
- Latest trends in life science funding.
- The best ways for small companies to raise capital to generate big value.
- Inside the head of a life science investor.
- Taking life science to the stock market. The if. The why. The how.
- Cellink’s breathtaking journey from the lab to the stock market.
- Practical advice when considering a stock listing.
